RxHero - Master Top 250 Drugs
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- 4.026 ratings
- Paid $2.99
- Updated
- Observed
Ratings
Observed264.0★ average
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived26/100Weak · low confidence
Own RxHero - Master Top 250 Drugs? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made RxHero - Master Top 250 Drugs? Add a “Tracked in Medical” badge to your site
About RxHero - Master Top 250 DrugsObserved
RxHero - Master Top 250 Drugs is a Medical app by ClinCalc LLC on the United States App Store. Released Apr 23, 2019; last updated Sep 21, 2020 (version 2.0). RxHero - Master Top 250 Drugs costs $2.99 to download.
As of Oct 8, 2026, RxHero - Master Top 250 Drugs has a 4.0-star average rating from 26 ratings on the United States App Store. MRRBeam rates the success of RxHero - Master Top 250 Drugs 21/100 (early stage).
RxHero is an educational game for healthcare students and professionals to learn the top 250 medications in the outpatient setting (also known as the Top 200 Drugs or Top 300 Drugs).
- Success score
- 21/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- ClinCalc LLC
Loading the full report…
Top Medical apps
The most successful Medical apps MRRBeam tracks in the United States.
RxHero - Master Top 250 Drugs: common questions
- What is RxHero - Master Top 250 Drugs?
- RxHero - Master Top 250 Drugs is a Medical app developed by ClinCalc LLC, available on the App Store. It was first released on Apr 23, 2019.
- How is RxHero - Master Top 250 Drugs rated?
- RxHero - Master Top 250 Drugs has a 4.0-star average rating from 26 ratings on the United States App Store as of Oct 8, 2026.
- How much does RxHero - Master Top 250 Drugs cost?
- RxHero - Master Top 250 Drugs costs $2.99 to download.
- Is RxHero - Master Top 250 Drugs successful?
- MRRBeam rates the success of RxHero - Master Top 250 Drugs 21/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was RxHero - Master Top 250 Drugs last updated?
- RxHero - Master Top 250 Drugs was last updated on Sep 21, 2020 (version 2.0).
- What are alternatives to RxHero - Master Top 250 Drugs?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to RxHero - Master Top 250 Drugs?
- MRRBeam's opportunity score for RxHero - Master Top 250 Drugs is 26/100. Limited opening: an older app, little observable demand and low price points.